Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
May 31, 2026 30.84%
February 28, 2026 33.25%
November 30, 2025 31.58%
August 31, 2025 31.46%
May 31, 2025 30.80%
February 28, 2025 32.70%
November 30, 2024 31.57%
August 31, 2024 30.89%
May 31, 2024 29.85%
February 29, 2024 32.12%
November 30, 2023 30.82%
August 31, 2023 30.14%
May 31, 2023 29.80%
February 28, 2023 31.94%
November 30, 2022 30.20%
August 31, 2022 29.66%
May 31, 2022 29.48%
February 28, 2022 31.81%
November 30, 2021 30.88%
August 31, 2021 30.33%
May 31, 2021 29.43%
February 28, 2021 30.51%
November 30, 2020 30.59%
August 31, 2020 29.93%
May 31, 2020 29.45%
Date Value
February 29, 2020 31.29%
November 30, 2019 29.24%
August 31, 2019 29.59%
May 31, 2019 29.48%
February 28, 2019 30.27%
November 30, 2018 28.81%
August 31, 2018 28.83%
May 31, 2018 28.58%
February 28, 2018 29.87%
November 30, 2017 28.48%
August 31, 2017 28.33%
May 31, 2017 28.45%
February 28, 2017 28.82%
November 30, 2016 28.09%
August 31, 2016 27.22%
May 31, 2016 27.31%
February 29, 2016 28.18%
November 30, 2015 27.75%
August 31, 2015 27.58%
May 31, 2015 28.05%
February 28, 2015 28.05%
November 30, 2014 27.27%
August 31, 2014 27.42%
May 31, 2014 27.38%
February 28, 2014 27.45%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Sundrug Co., Ltd. 25.72%
TSURUHA Holdings, Inc. 30.11%
COSMOS Pharmaceutical Corp. 20.66%
MatsukiyoCocokara & Co. 35.11%
Ain Holdings, Inc. 12.85%